Orofacial Pain of Muscular Origin Is Not Associated with Herpes Virus-6 Infection: A Pilot Study

Aims: To carry out a pilot study to test the hypothesis that human herpes virus-6 (HHV-6) infection or reactivation plays a role in the pathogenesis of temporomandibular disorders (TMD) of muscular origin (ie, localized myalgia). Methods: Sixteen patients with localized myalgia participated in this pilot study. Thirty-six healthy individuals served as controls. The participants were examined clinically for the presence of the TMD according to the Research Diagnostic Criteria for TMD, and the salivary levels of HHV-6 were measured by quantitative polymerase chain reaction (qPCR). The Z test, Student t test, and Mann-Whitney U test were used as appropriate. Results: The results demonstrated that 77.8% of healthy individuals were HHV-6 positive, but a significantly lower proportion (43.8%) of the TMD patients with localized myalgia were positive for HHV-6 (P < .05, Fisher exact test). The levels of HHV-6B DNA were lower in the saliva of HHV-6–positive TMD patients with localized myalgia (median: 564 genome/mL; range: 184 to 5,835 genome/mL) than in that of healthy individuals (median: 1,081 genome/mL; range: 193 to 8,807 genome/mL), but the difference was not statistically significant (P > .05, Mann-Whitney U test). Conclusion: The results of this pilot study indicate that HHV-6 infection or reactivation does not appear to play a role in the pathogenesis of TMD reflecting a localized myalgia.

chronic fatigue syndrome; herpes virus 6; myalgia; saliva; temporomandibular disorders

1. Tajiri H, Tanaka-Taya K, Ozaki Y, Okada S, Mushiake S, Yamanishi K. Chronic hepatitis in an infant, in association with human herpesvirus-6 infection. J Pediatr 1997;131:473–475.

2. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995;21:571–576.

3. Akashi K, Eizuru Y, Sumiyoshi Y, et al. Brief report: Severe infec-tious mononucleosis-like syndrome and primary human herpes-virus 6 infection in an adult. N Engl J Med 1993;329:168–171.

4. Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992;116:103–113.

5. Di Luca D, Zorzenon M, Mirandola P, Colle R, Botta GA, Cassai E. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol 1995;33:1660–1661.

6. Prezioso PJ, Cangiarella J, Lee M, et al. Fatal disseminated infection with human herpesvirus-6. J Pediatr 1992;120:921–923.

7. Soldan SS, Berti R, Salem N, et al. Association of human her-pes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997;3:1394–1397.

8. Black JB, Inoue N, Kite-Powell K, Zaki S, Pellett PE. Frequent isolation of human herpesvirus 7 from saliva. Virus Res 1993; 29:91–98.

9. Mukai T, Yamamoto T, Kondo T, et al. Molecular epidemiological studies of human herpesvirus 6 in families. J Med Virol 1994; 42:224–227.

10. Di Luca D, Mirandola P, Ravaioli T, et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995;45:462–468.

11. Tanaka-Taya K, Kondo T, Mukai T, et al. Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol 1996;48:88–94.

12. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000;160: 221–227.

13. Ablashi DV, Eastman HB, Owen CB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000;16:179–191.

14. Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol 2006;37(Suppl 1):S39–S46.

15. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596–601.

16. Aubin JT, Collandre H, Candotti D, et al. Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol 1992; 30:2524.

17. Aubin JT, Poirel L, Robert C, Huraux JM, Agut H. Identification of human herpesvirus 6 variants A and B by amplimer hybridization with variant-specific oligonucleotides and amplification with variant-specific primers. J Clin Microbiol 1994;32:2434–2440.

18. Isegawa Y, Mukai T, Nakano K, et al. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and

B. J Virol 1999;73:8053–8063.

19. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE. Human herpesvirus 6B genome sequence: Coding content and comparison with human herpesvirus 6A. J Virol 1999;73:8040–8052.

20. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief re-port: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356–1360.

21. Dworkin SF, LeResche L. Research diagnostic criteria for tem-poromandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

22. Goldberg DP, Williams P. User’s Guide to the General Health Questionnaire. Windsor: NFFR-Nelson, 1988.

23. Boutolleau D, Duros C, Bonnafous P, et al. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 2006;35:257–263.

24. Flamand L, Gravel A, Boutolleau D, et al. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol 2008;46:2700–2706.

25. Tan BS, Tiong KH, Muruhadas A, et al. CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells. Mol Cancer Ther 2011;10:1982–1992.

26. De Leeuw R. Orofacial Pain: Guidelines for Asssessment, Diagnosis, and Management. Chicago: Quintessence, 2008.

27. Dinos S, Khoshaba B, Ashby D, et al. A systematic review of chronic fatigue, its syndromes and ethnicity: Prevalence, severity, comorbidity and coping. Int J Epidemiol 2009;38:1554–1570.

28. Kim CH, Shin HC, Won CW. Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: Community-based primary care study. J Korean Med Sci 2005;20:529–534.

29. Laskin DM, Greene CS, Hylander WL. Temporomandibular Disorders: An Evidence-Based Approach to Diagnosis and Treatment. Chicago: Quintessence, 2006.

30. Chapenko S, Krumina A, Kozireva S, et al. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol 2006;37(Suppl 1):S47–S51.

31. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis 1999;5: 353–366.

32. Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet 1990;335: 1598–1599.

33. Agut H. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J Clin Virol 2011;52:164–171.